469 related articles for article (PubMed ID: 24091415)
21. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
[TBL] [Abstract][Full Text] [Related]
22. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
Sheridan J; Strang J; Taylor C; Barber N
Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
[TBL] [Abstract][Full Text] [Related]
23. Practical strategies and perceptions from community pharmacists following their experiences with conducting pharmacy practice research: a qualitative content analysis.
De Vera MA; Campbell NKJ; Chhina H; Galo JS; Marra C
Int J Pharm Pract; 2018 Aug; 26(4):302-309. PubMed ID: 29071805
[TBL] [Abstract][Full Text] [Related]
24. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.
Butt F; Ream E
Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523
[TBL] [Abstract][Full Text] [Related]
25. Supervising pharmacists' opinions about pharmacy technicians as immunizers.
Bertsch TG; McKeirnan KC; Frazier K; VanVoorhis L; Shin S; Le K
J Am Pharm Assoc (2003); 2019; 59(4):527-532. PubMed ID: 31036525
[TBL] [Abstract][Full Text] [Related]
26. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
27. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.
Paudyal V; Hansford D; Cunningham S; Stewart D
Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237
[TBL] [Abstract][Full Text] [Related]
28. Pharmacist self-reported antidepressant medication counseling.
Cannon-Breland ML; Westrick SC; Kavookjian J; Berger BA; Shannon DM; Lorenz RA
J Am Pharm Assoc (2003); 2013; 53(4):390-9. PubMed ID: 23892812
[TBL] [Abstract][Full Text] [Related]
29. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a pharmacist-led, medicines education program for Aboriginal Health Workers.
McRae M; Taylor SJ; Swain L; Sheldrake C
Rural Remote Health; 2008; 8(4):946. PubMed ID: 19093711
[TBL] [Abstract][Full Text] [Related]
31. Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.
Doong K; Berenbrok LA; Coley KC; Carroll JC; Richardson R; Antinopoulos BC; Patel A; McGivney MS
J Am Pharm Assoc (2003); 2019; 59(4S):S25-S31. PubMed ID: 31080149
[TBL] [Abstract][Full Text] [Related]
32. Perceptions of pharmaceutical care among pharmacists offering compounding services.
Yancey V; Yakimo R; Perry A; McPherson TB
J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
[TBL] [Abstract][Full Text] [Related]
33. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan.
Almansour HA; Chaar B; Saini B
Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428
[TBL] [Abstract][Full Text] [Related]
34. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
Fathima M; Saini B; Foster JM; Armour CL
Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
[TBL] [Abstract][Full Text] [Related]
35. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems.
Tucker R; Stewart D
Int J Pharm Pract; 2015 Dec; 23(6):390-8. PubMed ID: 25689029
[TBL] [Abstract][Full Text] [Related]
36. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
37. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
Watkins A; McKee J; Hughes C; Pfeiffenberger T
J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
[TBL] [Abstract][Full Text] [Related]
38. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
Thornton JD; Lyvers E; Scott VGG; Dwibedi N
J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
[TBL] [Abstract][Full Text] [Related]
39. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
Singh HK; Kennedy GA; Stupans I
Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
[TBL] [Abstract][Full Text] [Related]
40. Pediatric medication use experiences and patient counseling in community pharmacies: Perspectives of children and parents.
Abraham O; Brothers A; Alexander DS; Carpenter DM
J Am Pharm Assoc (2003); 2017; 57(1):38-46.e2. PubMed ID: 27843107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
